NCT02445911View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

KQ-791

Capsules administered orally

DRUG

Placebo

Capsules administered orally

Trial Locations (4)

32809

Orlando Clinical Research Center, Orlando

33014

Clinical Pharmacology of Miami, Inc., Miami

68502

Celerion, Lincoln

85283

Celerion, Tempe

Sponsors
All Listed Sponsors
lead

Kaneq Bioscience Limited

OTHER